Side-by-side on funding, valuation, status, and the rest of the FOBI roster.
Produces micro-stimulators for peripheral nerve stimulation to treat chronic pain without the need for leads or extension wires.
Joint venture between GSK and Verily developing bioelectronic medicines that modulate peripheral nerves for chronic disease treatment.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →
| Valuation | $533MAcquisition price | — |
| Founders | Keegan Harper | — |
| Profile | View on FOBI → | View on FOBI → |